Navigation Links
Prosum Kicks Off Crowd Funding for Cancer Research
Date:8/9/2012

RENO, Nev., Aug. 9, 2012 /PRNewswire/ -- Prosum Breast Cancer Research, Inc. announces a Crowd Funding financing project to jump start its first research project to build the "You Will Be the Cure" for early detection breast health awareness and research. "Our first awareness project focuses on communicating individual experiences of women to educate all about the value with early detection starting at age 20," says Dave Wertzberger, Executive Director.

"We believe early detection education is much more than statistics and technology—women are the cure. The collective experience of survivors needs to be shared. We are convinced the profiles of women who have 'been there and done that' will provide invaluable awareness for women of all ages to advance the cure starting with early detection," adds Cindy Lain, Community Affairs Director.  "In addition, we see a number of early detection technologies coming to market and our goal is to confidentially involve volunteers with these technologies to improve device early detection usability and value," continues Wertzberger.

"Our Crowd Funding site at Rockethub.com provides one location to describe project goals and how individuals can support a new level of information for improving early detection and survival," says Wertzberger. "The Crowd Funding approach simplifies fund raising with contributions of $10, or more, while engaging folks wherever there is an Internet connection," says Wertzberger.

Prosum's awareness project will collect video histories as well as personal profiles in preparation for an updated web site for those who wish to share their stories to be part of our "You Will Be the Cure" awareness and research on early detection.  The fund raising goal is $30,000.  Any additional funds will be used to develop a confidential Breast Cancer History Database to improve early detection devices for positive change.

Press Ctrl, Click to follow the link Prosum Rocket Hub Link

About Prosum Breast Cancer Research

Prosum Research Foundation, Inc., dba Prosum Breast Cancer Research, (PBCR) is based in Reno, NV.  Founded in 2008, PBCR is a non-profit foundation dedicated to the dissemination of breast health information and education while advancing the state-of-the art of early detection of breast cancer to enhance current detection technologies to delivery early screening to more women by any physician.  www.prosumresearch.org 

For more information, contact: Dave Wertzberger, Executive Director 800-448-4981 dwertzberger@prosumresearch.org


'/>"/>
SOURCE Prosum Breast Cancer Research, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Pharmatech Oncology Receives Phase 2 SBIR Funding for Just-In-Time Enrollment Model
2. RD Legal Funding Provides Immediate Settlement Financing to Growing Number of Yaz and Yasmin Plaintiffs
3. DePuy & Transvaginal Mesh Lawsuit Settlement Funding Leads Legal-Bay to Banner 2nd Quarter
4. BONESUPPORT Closes Second Tranche of Funding
5. Elsevier and Russias Skolkovo Foundation Sign Access Agreement to SciVerse Scopus and SciVal Funding
6. Igenica Closes $33 Million in Series C Funding
7. Lexicon Receives Funding for Phase 2 Clinical Trial of LX4211 in Type 1 Diabetes
8. Xtelligent Media Raises $800K in Funding and Launches EHRintelligence.com
9. Independa Closes Convertible Note Funding at $2.35 Million
10. Amgen Announces Termination Of Ganitumab Phase 3 Study For Futility In Metastatic Pancreatic Cancer
11. OncoGenex Announces Initiation of the Phase 3 "AFFINITY" Trial for Patients with Advanced Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2017)... 2017  BDI Group subsidiary Pathway Purchasing Network, ... organization serving specialty pharmacies, home infusion companies and ... significant, value-added member programs designed to help organizations ... and improve access and affordability for patients who ... Pathway has worked ...
(Date:7/10/2017)... , July 10, 2017 Locus Biosciences ... Note to support the development of CRISPR-Cas3 antimicrobial therapeutics. ... Limited, a leading Chinese Internet services provider, and joined ... advance multiple infectious disease product programs targeting antibiotic resistant ... Founded by Dr. Rodolphe Barrangou ...
(Date:7/5/2017)... , July 5, 2017 Wolfmet 3D ... answer as physics and manufacturing combine to progress molecular radiotherapy ... existing SPECT systems are unable to accurately quantify the radiation ... limited information regarding the success of this radiotherapy treatment has ... ...
Breaking Medicine Technology:
(Date:7/23/2017)... Melbourne, Fla. (PRWEB) , ... July 23, 2017 ... ... Stern, M.D., has joined Florida Pain Relief Group – Melbourne, a practice owned ... to board certification in interventional pain management, Dr. Stern also is certified in ...
(Date:7/22/2017)... , ... July 22, 2017 , ... ... year with the majority of patients not requiring pain medication after three months ... Sports Medicine’s Annual Meeting today in Toronto, Ontario, Canada found that those ...
(Date:7/21/2017)... ... July 21, 2017 , ... The Wettstein Agencies, a ... in the greater Denver region, is announcing a charity drive to help raise ... kind of epilepsy. , Until a few months ago, Dominik was a healthy ...
(Date:7/21/2017)... Saint Paul, Minnesota (PRWEB) , ... July 21, ... ... architectural designers BWBR recently were selected to renovate and improve the Ramsey County ... building immediately adjacent to Regions Hospital, the $2.5 million project is scheduled to ...
(Date:7/21/2017)... ... , ... Bernard R. Bach, Jr., MD, orthopaedic surgeon at Rush University Medical ... Sports Medicine (AOSSM) , received the 2017 Robert E. Leach Sports Medicine Leadership award ... prestigious award is given annually to honor those who have made a significant contribution ...
Breaking Medicine News(10 mins):